A phase II trial of circadian-timed paclitaxel and cisplatin therapy in metastatic breast cancer

Nonparametric Estimation from Incomplete Observations

Edward L. Kaplan, Paul Meier · Journal of the American Statistical Association · 1958 · 39.1K citations

Public Health, Biostatistics, Mathematics +10

Reporting results of cancer treatment

A. B. Miller, Barth Hoogstraten, M. Staquet et al. · Cancer · 1981 · 7.9K citations

Pharmacy, Oncology, Clinical Data Management +16

Evaluation of survival data and two new rank order statistics arising in its consideration.

Nathan Mantel · PubMed · 1966 · 7.6K citations

Public Health, Biostatistics, Survival Analysis +11

Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer

William P. McGuire, William J. Hoskins, Mark F. Brady et al. · New England Journal of Medicine · 1996 · 2.9K citations · Full text

Medicine, Gynecology, Oncology +16

THE IMPACT OF NATIONAL CANCER ACT

Frankie A. Holmes, Ronald S. Walters, Richard L. Theriault et al. · JNCI Journal of the National Cancer Institute · 1991 · 803 citations

Medicine, Oncology, Pharmacology +10